Reuters logo
BRIEF-Teva wins generic Uceris patent trial
October 31, 2017 / 2:11 PM / a month ago

BRIEF-Teva wins generic Uceris patent trial

Oct 31 (Reuters) - Teva Pharmaceutical Industries Ltd :

* Teva wins generic uceris® patent trial

* U.S. Court ruled in Teva’s favor in patent litigation involving its ANDA directed to generic version of Valeant’s uceris (budesonide ER) tablets​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below